Location History:
- Biberch, DE (1997)
- Biberach, DE (1993 - 2013)
- Biberach an der Riss, DE (2016 - 2017)
- Birerach an der Riss, DE (2019)
Company Filing History:
14 out of 1,536 
10 out of 149 
9 out of 133 
Years Active: 1993-2019
Areas of Expertise:
Title: Innovations and Contributions of Uwe Joerg Ries in the Field of Pharmaceuticals
Introduction
Uwe Joerg Ries, based in Biberach, Germany, is a prominent inventor in the pharmaceutical sector with a remarkable portfolio of 42 patents. His innovations focus on developing critical methods and compounds that have substantial implications in medicine, particularly in treating various diseases.
Latest Patents
Ries's latest patents include a stereoselective process related to the preparation of specific compounds, which showcases his expertise in synthetic methodologies. Furthermore, he has developed substituted bicyclic dihydropyrimidinones, which serve as inhibitors of neutrophil elastase activity. This invention is particularly significant as it includes pharmaceutical compositions aimed at treating pulmonary, gastrointestinal, and genitourinary diseases, as well as autoimmune disorders and cancers.
Career Highlights
Throughout his career, Uwe Joerg Ries has worked with recognized entities such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma KG. His tenure at these organizations has not only solidified his reputation as an innovator but also contributed to the advancement of pharmaceutical research and development.
Collaborations
Ries has collaborated with notable colleagues, including Wolfgang Wienen and Norbert Hauel. These partnerships reflect a commitment to collaborative innovation aimed at overcoming complex medical challenges through advanced research.
Conclusion
Uwe Joerg Ries exemplifies the impact of innovation in pharmaceuticals, with a strong portfolio of patents that address critical health issues. His work not only advances scientific knowledge but also translates into meaningful solutions that benefit society. As he continues his innovative journey, the medical field can anticipate further breakthroughs stemming from his contributions.